{"id":78,"date":"2025-08-27T17:57:48","date_gmt":"2025-08-27T20:57:48","guid":{"rendered":"http:\/\/localhost\/colfarma\/?p=78"},"modified":"2026-01-26T13:23:48","modified_gmt":"2026-01-26T16:23:48","slug":"sifilis-la-vieja-enfermedad-de-transmision-sexual-que-volvio-con-todo","status":"publish","type":"post","link":"https:\/\/colfarma.info\/pilar\/sifilis-la-vieja-enfermedad-de-transmision-sexual-que-volvio-con-todo\/","title":{"rendered":"El CIMF recomienda: Alergia a la prote\u00edna de la leche de vaca y vacunasS\u00edfilis, la vieja enfermedad de transmisi\u00f3n sexual que volvi\u00f3 con todo"},"content":{"rendered":"<div data-olk-copy-source=\"MessageBody\">El Ministerio de Salud explica que\u00a0<em>\u00aba trav\u00e9s de la Direcci\u00f3n de Control de Enfermedades\u00a0Inmunoprevenibles (DiCEI), y luego de una consulta con la Comisi\u00f3n Nacional de Seguridad en Vacunas (CoNaSeVa), en el marco del sistema nacional de vigilancia de Eventos\u00a0Supuestamente Atribuibles a la Vacunaci\u00f3n o Inmunizaci\u00f3n (ESAVI), ha identificado una\u00a0se\u00f1al de alerta vinculada a la administraci\u00f3n de vacunas triple viral (SRP) y doble viral (SR)\u00a0del laboratorio Serum Institute of India Pvt. Ltd., en ni\u00f1os con\u00a0antecedentes de alergia a la\u00a0prote\u00edna de la leche de vaca (APLV).\u00bb<\/em><\/div>\n<div>\n<p>En el comunicado se informa que la alerta se debe a 3 casos\u00a0en investigaci\u00f3n en los que se aplic\u00f3 la vacuna mencionada y se presentaron las reacciones al\u00e9rgicas, que posteriormente fueron tratados con \u00e9xito.\u00a0 Aunque todav\u00eda no se comprob\u00f3 la causalidad directa, esta medida prevendr\u00eda casos futuros.<\/p>\n<p>Las vacunas triple o doble viral producidas por el Serum Institute of India Pvt. Ltd.\u00a0pueden ser administradas a toda la poblaci\u00f3n que no tenga antecedentes de Alergia a la\u00a0Prote\u00edna de Leche de Vaca (APLV)<\/p>\n<p>Puede leer el informe completo en el Reporte de la RPVF N\u00b0 285:\u00a0<a title=\"Direcci\u00f3n URL original: https:\/\/colfarma.org.ar\/wp-content\/uploads\/REPORTE-RPVF-285.pdf. Haga clic o pulse si conf\u00eda en este v\u00ednculo.\" href=\"https:\/\/nam10.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fcolfarma.org.ar%2Fwp-content%2Fuploads%2FREPORTE-RPVF-285.pdf&amp;data=05%7C02%7Cgcarral%40colfarma.org.ar%7Cce0903f47e1f4a5e5e6608de5aabf132%7C94fa8344bb974cc1b7b5a3d9ddf78a6f%7C0%7C0%7C639047891759951788%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=4MXP8gxR843PvesEHk3JXpbRmYiefra6wFxtsYOqo9E%3D&amp;reserved=0\" target=\"_blank\" rel=\"noopener noreferrer\" data-auth=\"NotApplicable\" data-linkindex=\"0\">https:\/\/colfarma.org.ar\/wp-content\/uploads\/REPORTE-RPVF-285.pdf<\/a><\/p>\n<\/div>\n\n\n<figure class=\"wp-block-gallery has-nested-images columns-default is-cropped wp-block-gallery-1 is-layout-flex wp-block-gallery-is-layout-flex\"><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>El Ministerio de Salud explica que\u00a0\u00aba trav\u00e9s de la Direcci\u00f3n de Control de Enfermedades\u00a0Inmunoprevenibles (DiCEI), y luego de una consulta con la Comisi\u00f3n Nacional de Seguridad en Vacunas (CoNaSeVa), en el marco del sistema nacional de vigilancia de Eventos\u00a0Supuestamente Atribuibles<\/p>\n","protected":false},"author":1,"featured_media":79,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5],"tags":[],"class_list":["post-78","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias"],"acf":[],"_links":{"self":[{"href":"https:\/\/colfarma.info\/pilar\/wp-json\/wp\/v2\/posts\/78","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/colfarma.info\/pilar\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/colfarma.info\/pilar\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/colfarma.info\/pilar\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/colfarma.info\/pilar\/wp-json\/wp\/v2\/comments?post=78"}],"version-history":[{"count":4,"href":"https:\/\/colfarma.info\/pilar\/wp-json\/wp\/v2\/posts\/78\/revisions"}],"predecessor-version":[{"id":511,"href":"https:\/\/colfarma.info\/pilar\/wp-json\/wp\/v2\/posts\/78\/revisions\/511"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/colfarma.info\/pilar\/wp-json\/wp\/v2\/media\/79"}],"wp:attachment":[{"href":"https:\/\/colfarma.info\/pilar\/wp-json\/wp\/v2\/media?parent=78"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/colfarma.info\/pilar\/wp-json\/wp\/v2\/categories?post=78"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/colfarma.info\/pilar\/wp-json\/wp\/v2\/tags?post=78"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}